Presentation

TCT-61: Clinical Outcomes Following Complete Bioresorption of the Absorb Everolimus-Eluting Bioresorbable Scaffold: Four-year Results from the ABSORB III Trial

Presenter: Dean J. Kereiakes

September 21, 2018

REGISTER for free or LOG IN to view this content

TCT-61: Clinical Outcomes Following Complete Bioresorption of the Absorb Everolimus-Eluting Bioresorbable Scaffold: Four-year Results from the ABSORB III Trial

Coronary

Presentation

TCT 2018

DES/BRS/DCB

Up Next

Presentation

TCT-42: An Early Feasibility Study to Assess Safety and Effectiveness of the Transfemoral JenaValve Pericardial TAVR System in the Treatment of Patients With Symptomatic Severe Aortic Stenosis (AS)

Presenter: Hendrik Treede

September 21, 2018

More slides +

Presentation

TCT-54: The Distribution of High-Risk Plaques with Respect to Artery Stenosis in Non-Culprit Non-Ischemic Native Coronary Lesions of Diabetic Patients data from COMBINE OCT-FFR study

Presenter: Tomasz Roleder

September 21, 2018

Presentation

TCT-46: Mitral Valve Gradient, Heart Failure Admissions and One Year Mortality Following MitraClip Repair in 5,378 Patients: Results from the ACC/STS TVT Registry

Presenter: Lowie Van Assche

September 21, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.